Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Phase II Study of docetaxel, estramustine and low dose hydrocortisone in hormone refractory prostate cancer

A Phase II Study of docetaxel, estramustine and low dose hydrocortisone in hormone refractory prostate cancer. Proc Am Soc Clin Onc. 1999; 18:295.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.